Apellis Announces Top-Line Results from Phase 3 DERBY and OAKS Studies in Geographic Atrophy (GA) and Plans to Submit NDA to FDA in the First Half of 2022
Go back to Apellis Announces Top-Line Results from Phase 3 DERBY and OAKS Studies in Geographic Atrophy (GA) and Plans to Submit NDA to FDA in the First Half of 2022| American Pallet Leasing, Inc. (NASDAQ: APLS) | Delayed: 41.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.03 | 52 Week High | $0.01 | |||
| Open | $41.03 | 52 Week Low | $0.00 | |||
| Day High | $41.03 | P/E | N/A | |||
| Day Low | $41.03 | EPS | $0.00 | |||
| Volume | 127,770 | |||||
